Hydroxymitragynine Above a Specified Threshold in Schedule I; Extension of Comment Period
The Office of the Assistant Secretary for Health (OASH or we) is extending the comment period to solicit input and comments on a Request for Information (RFI) on a proposed thre...
[Docket No. HHS-OASH-2026-0232] Temporary Placement of 7-
AGENCY:
Office of the Assistant Secretary for Health, Department of Health and Human Services.
ACTION:
Notice; request for information; extension of comment period for the Request for Information and for its information collection provisions.
SUMMARY:
The Office of the Assistant Secretary for Health (OASH or we) is extending the comment period to solicit input and comments on a Request for Information (RFI) on a proposed threshold for 7-hydroxymitragynine (7-OH) scheduling under the Controlled Substances Act that appeared in the
Federal Register
of July 6, 2026. Public comments submitted to this docket will be provided by the Secretary for Health and Human Services for consideration by the Attorney General. We are taking this action in response to a request for an extension to allow interested persons additional time to provide comments and input.
DATES:
Submit either electronic or written comments, data, or information by September 10, 2026.
ADDRESSES:
Request for Information (RFI) Docket:
You may examine the full RFI docket at
regulations.gov
under HHS-OASH-2026-0232. To submit a response, click the “Comment” button inside Docket: HHS-OASH-2026-0232 and follow all instructions.
In the
Federal Register
of July 6, 2026, we published an RFI entitled “Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information” with a comment period that closed on July 31, 2026. This RFI sought input on the proposed 7-OH threshold that was listed by the Drug Enforcement Administration (DEA) that was issued in the
Federal Register
entitled “Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I.”
OASH has received a request for an extension of the comment period on this RFI to allow any interested persons additional time to provide comments. OASH has considered the request and is granting the extension of the comment period to allow any interested persons additional opportunity to provide comments. OASH believes that this extension allows adequate time for any interested persons to fully consider and submit comments.
Note that OASH is not soliciting comments on any permanent scheduling decision, the general safety or utility of kratom-derived products, or other policy questions outside the scope of the threshold determination for temporary scheduling. Public comments submitted to this docket will be provided by the Secretary for Health and Human Services for consideration by the Attorney General.
Brian Christine
Assistant Secretary for Health, Department of Health and Human Services.